Literature DB >> 33770322

LINC01515 promotes nasopharyngeal carcinoma progression by serving as a sponge for miR-325 to up-regulate CDCA5.

Dan Liu1, Hao Gong2, Zezhang Tao3, Shiming Chen3, Yonggang Kong3, Bokui Xiao4.   

Abstract

Long non-coding RNAs (LncRNAs) have gained widespread interest and attention as vital regulators in cancer occurrence and development. Nonetheless, the functions and mechanisms of lncRNAs involved in nasopharyngeal carcinoma (NPC) are largely unknown. By analysing the data from GSE61218, we identified a novel lncRNA LINC01515 which is altered in NPC. A series of experiments were performed to examine the exact roles of LINC01515 as well as the molecular mechanisms by which LINC01515 acted in NPC. LINC01515 expression was increased in NPC and that high LINC01515 expression was associated with a worse prognosis. Functionally, depletion of LINC01515 resulted in an inhibition of cell proliferation, migration and invasion, while apoptosis was promoted. Mechanistically, LINC01515 facilitated cell division cycle associated 5 (CDCA5) expression via serving as a sponge for miR-325. And more notably, miR-325 suppressed NPC progression in vitro by targeting CDCA5. Furthermore, the anti-tumor property induced by LINC01515 knockdown was partially reversed due to the overexpression of CDCA5. Taken together, LINC01515 exerted the carcinogenic effect in NPC through regulating miR-325/CDCA5 pathway. Our findings shed light on the possibility of exploiting LINC01515 as a prognostic biomarker or therapeutic target in NPC.

Entities:  

Keywords:  Cell division cycle associated 5; LINC01515; Nasopharyngeal carcinoma; miR-325

Year:  2021        PMID: 33770322     DOI: 10.1007/s10735-021-09969-x

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  21 in total

Review 1.  Nasopharyngeal carcinoma.

Authors:  Yu-Pei Chen; Anthony T C Chan; Quynh-Thu Le; Pierre Blanchard; Ying Sun; Jun Ma
Journal:  Lancet       Date:  2019-06-06       Impact factor: 79.321

Review 2.  Cytoplasmic functions of long noncoding RNAs.

Authors:  Ji Heon Noh; Kyoung Mi Kim; Waverly G McClusky; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-03-08       Impact factor: 9.957

Review 3.  Current Perspectives on Nasopharyngeal Carcinoma.

Authors:  Hui Mei Lee; Kazuhida Shaun Okuda; Fermín E González; Vyomesh Patel
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.

Authors:  Shaoqing Chen; Linrong Lv; Zhengyu Zhan; Xiaolang Wang; Zhenyu You; Xiao Luo; Haoyuan You
Journal:  J Cell Physiol       Date:  2019-11-19       Impact factor: 6.384

Review 5.  Genetic and epigenetic landscape of nasopharyngeal carcinoma.

Authors:  Wei Dai; Hong Zheng; Arthur Kwok Leung Cheung; Maria Li Lung
Journal:  Chin Clin Oncol       Date:  2016-04

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  AR-induced long non-coding RNA LINC01503 facilitates proliferation and metastasis via the SFPQ-FOSL1 axis in nasopharyngeal carcinoma.

Authors:  Shi-Wei He; Cheng Xu; Ying-Qing Li; Ying-Qin Li; Yin Zhao; Pan-Pan Zhang; Yuan Lei; Ye-Lin Liang; Jun-Yan Li; Qian Li; Yang Chen; Sheng-Yan Huang; Jun Ma; Na Liu
Journal:  Oncogene       Date:  2020-07-13       Impact factor: 9.867

Review 8.  Exploring the mechanisms behind long noncoding RNAs and cancer.

Authors:  Maggie M Balas; Aaron M Johnson
Journal:  Noncoding RNA Res       Date:  2018-03-31

9.  MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.

Authors:  Tao Lin; Shiming Zhou; Hui Gao; Yuqiao Li; Lijiang Sun
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

10.  CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.

Authors:  Guanghou Fu; Zhijie Xu; Xiaoyi Chen; Hao Pan; Yiming Wang; Baiye Jin
Journal:  J Cancer       Date:  2020-02-10       Impact factor: 4.207

View more
  2 in total

1.  Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non-small cell lung cancer cells via p53-p21 signaling pathway.

Authors:  Wei Shen; Dimin Tong; Jie Chen; Hongxiang Li; Zeyang Hu; Shuguang Xu; Sufang He; Zhen Ge; Jianan Zhang; Qiqi Mao; Hang Chen; Guodong Xu
Journal:  J Clin Lab Anal       Date:  2022-04-04       Impact factor: 3.124

2.  A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.

Authors:  Shujia Chen; Peiyan Liu; Lili Zhao; Ping Han; Jie Liu; Hang Yang; Jia Li
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.